| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.940 | 11.271 | 6.097 | 2.532 | 0 |
| Total Income - EUR | - | - | - | - | - | 2.940 | 11.556 | 6.760 | 2.532 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 6.090 | 23.765 | 19.199 | 18.777 | 18.062 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -3.150 | -12.210 | -12.440 | -16.245 | -18.062 |
| Net Profit/Loss - EUR | - | - | - | - | - | -3.229 | -12.323 | -12.507 | -16.270 | -18.062 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Rafelmed International S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 21 | 12 | 4 | 0 | 0 |
| Current Assets | - | - | - | - | - | 2.343 | 11.497 | 8.667 | 5.934 | 7.008 |
| Inventories | - | - | - | - | - | 0 | 2.439 | 2.039 | 68 | 0 |
| Receivables | - | - | - | - | - | 2.173 | 7.222 | 4.432 | 5.203 | 6.370 |
| Cash | - | - | - | - | - | 170 | 1.836 | 2.196 | 662 | 638 |
| Shareholders Funds | - | - | - | - | - | -3.188 | -15.441 | -27.995 | -44.180 | -61.995 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 5.552 | 26.950 | 36.666 | 50.114 | 69.004 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Rafelmed International S.r.l.